Multiple Myeloma: Lytic Bone Lesions of the Skull.

Q3 Medicine Acta neurologica Taiwanica Pub Date : 2021-06-01
Umberto G Rossi, Anna Maria Ierardi, Maurizio Cariati
{"title":"Multiple Myeloma: Lytic Bone Lesions of the Skull.","authors":"Umberto G Rossi,&nbsp;Anna Maria Ierardi,&nbsp;Maurizio Cariati","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A 77-year-old woman with a 1 years history of Multiple Myeloma (MM) presented with headache, fatigue, and bone pain. She underwent whole body multi-detector computed tomographic (MD-CT) to evaluate possible lytic bone lesions. MD-CT showed small, multiple osteolytic lesions, particularly at the skull level (Figure 1, 2). MM is a plasma cell disorder. It is characterized by the monoclonal proliferation of malignant plasma cells (1,2). These cells, among their various characteristics, determine an infiltrate haemopoietic locations (1). Pathogenesis of MM related bone disease is the uncoupling of the bone remodelling process. There is an increased activity of osteoclastogenesis with the suppressed osteoblastic one, resulting in bone loss (1- 3). This process creates lytic lesions without reactive bone formation (2). Bone disease could be from single lytic lesion to multiple lytic lesions affecting any part of skeleton, preferably skull, spine and long bones (3). MD-CT, with dedicated low-dose protocols, is able to provide whole body skeletal volume information with a greater sensitivity than conventional X-ray studies in MM patients (3). Whole body CT with lowdose protocols can detect lesions with less than 5% trabecular bone destruction, and it is the first-line diagnostic imaging procedure for the diagnosis of lytic bone disease in patients affected by MM (4). When skull is involved, its most common MD-CT presentation is by numerous, well-circumscribed and punched-out lytic bone lesions, without reactive bone formation and diffuse osteopenia (1-5), as in the case presented.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":" ","pages":"81-82"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta neurologica Taiwanica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

A 77-year-old woman with a 1 years history of Multiple Myeloma (MM) presented with headache, fatigue, and bone pain. She underwent whole body multi-detector computed tomographic (MD-CT) to evaluate possible lytic bone lesions. MD-CT showed small, multiple osteolytic lesions, particularly at the skull level (Figure 1, 2). MM is a plasma cell disorder. It is characterized by the monoclonal proliferation of malignant plasma cells (1,2). These cells, among their various characteristics, determine an infiltrate haemopoietic locations (1). Pathogenesis of MM related bone disease is the uncoupling of the bone remodelling process. There is an increased activity of osteoclastogenesis with the suppressed osteoblastic one, resulting in bone loss (1- 3). This process creates lytic lesions without reactive bone formation (2). Bone disease could be from single lytic lesion to multiple lytic lesions affecting any part of skeleton, preferably skull, spine and long bones (3). MD-CT, with dedicated low-dose protocols, is able to provide whole body skeletal volume information with a greater sensitivity than conventional X-ray studies in MM patients (3). Whole body CT with lowdose protocols can detect lesions with less than 5% trabecular bone destruction, and it is the first-line diagnostic imaging procedure for the diagnosis of lytic bone disease in patients affected by MM (4). When skull is involved, its most common MD-CT presentation is by numerous, well-circumscribed and punched-out lytic bone lesions, without reactive bone formation and diffuse osteopenia (1-5), as in the case presented.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多发性骨髓瘤:颅骨溶解性骨病变。
77岁女性,多发性骨髓瘤(MM)病史1年,表现为头痛、疲劳和骨痛。她接受了全身多探测器计算机断层扫描(MD-CT)以评估可能的溶解性骨病变。MD-CT显示小而多发的溶骨病变,尤其是在颅骨水平(图1,2)。MM是一种浆细胞疾病。其特点是恶性浆细胞的单克隆增殖(1,2)。这些细胞,在其各种特性中,决定了浸润的造血位置(1)。MM相关骨病的发病机制是骨重塑过程的解偶联。破骨细胞生成活动增加,成骨细胞生成受到抑制,导致骨质流失(1- 3)。这一过程产生溶解性病变,但没有反应性骨形成(2)。骨病可能从单一溶解性病变发展为多发性溶解性病变,影响骨骼的任何部位,最好是头骨、脊柱和长骨(3)。能够提供比常规x线检查更敏感的MM患者全身骨骼体积信息(3)。低剂量全身CT可以检测到小于5%骨小梁破坏的病变,是MM患者溶解性骨病诊断的一线诊断成像程序(4)。当涉及颅骨时,其最常见的MD-CT表现是大量、界限明确、穿孔的溶解性骨病变。没有反应性骨形成和弥漫性骨减少(1-5),如病例所示。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta neurologica Taiwanica
Acta neurologica Taiwanica Medicine-Neurology (clinical)
CiteScore
1.30
自引率
0.00%
发文量
0
期刊最新文献
Acute Asymmetric Sensorimotor Variant of Chronic Inflammatory Demyelinating Polyneuropathy Triggered by mRNA-1273 COVID-19 Vaccination. Hemorrhagic shock due to retroperitoneal hemorrhage: a rare complication of lumbar puncture. Coexistence of IgLON5-IgG and SOX1-IgG in a Patient with Progressive Brainstem Dysfunction. Ross syndrome with chronic cough and RF positivity: a case report. Evidence-Based Taiwan Consensus Recommendations for the treatment of Parkinson's disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1